Wave Life Sciences (WVE) Assets Average (2015 - 2026)

Wave Life Sciences (WVE) has 12 years of Assets Average data on file, last reported at $570.9 million in Q2 2026.

• Quarterly Assets Average rose 111.18% year-over-year to $570.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $570.9 million (up 111.18% YoY) and the FY2025 annual result came in at $495.4 million, up 57.97% from the prior year.
• Assets Average slipped to $570.9 million in Q2 2026, from $611.0 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $611.0 million in Q1 2026 to a low of $163.9 million in Q4 2022.
• A 5-year average of $290.1 million and a median of $247.7 million in 2023 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average fell 28.27% — and 2026, when it soared 111.18%.
• Tracing WVE's Assets Average over 5 years: stood at $163.9 million in 2022, then surged by 44.82% to $237.4 million in 2023, then jumped by 49.67% to $355.4 million in 2024, then increased by 23.8% to $439.9 million in 2025, then increased by 29.78% to $570.9 million in 2026.
• The last three Assets Average figures came in at $570.9 million (Q2 2026), $611.0 million (Q1 2026), and $439.9 million (Q4 2025), per Business Quant data.